Cargando…

Discovery and validation of breast cancer subtypes

Mostrar otras versiones (1)

BACKGROUND: Previous studies demonstrated breast cancer tumor tissue samples could be classified into different subtypes based upon DNA microarray profiles. The most recent study presented evidence for the existence of five different subtypes: normal breast-like, basal, luminal A, luminal B, and ERB...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kapp, Amy V, Jeffrey, Stefanie S, Langerød, Anita, Børresen-Dale, Anne-Lise, Han, Wonshik, Noh, Dong-Young, Bukholm, Ida RK, Nicolau, Monica, Brown, Patrick O, Tibshirani, Robert
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574316/ https://www.ncbi.nlm.nih.gov/pubmed/16965636 http://dx.doi.org/10.1186/1471-2164-7-231

Ejemplares similares

Discovery and validation of breast cancer subtypes
por: Kapp, Amy V, et al.
Publicado: (2007)

TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer
por: Langerød, Anita, et al.
Publicado: (2007)

Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients
por: Langerød, A, et al.
Publicado: (2000)

TP53 mutations among molecular subtypes of HER2-positive tumors
por: Helland, Å, et al.
Publicado: (2005)

Gene expression profiles and the TP53 mutation status are powerful prognostic markers of breast cancer
por: Langerød, A, et al.
Publicado: (2005)

Intratumoural mRNA expression of genes from the oestradiol metabolic pathway and clinical and histopathological parameters of breast cancer
por: Yoshimura, Noriko, et al.
Publicado: (2004)

Age, estrogen, and immune response in breast adenocarcinoma and adjacent normal tissue
por: Quigley, David A., et al.
Publicado: (2017)

Evaluation of suitable reference genes for normalization of real-time reverse transcription PCR analysis in colon cancer
por: Sørby, Lise Aa, et al.
Publicado: (2010)

Expression of full-length p53 and its isoform Δp53 in breast carcinomas in relation to mutation status and clinical parameters
por: Baumbusch, Lars O, et al.
Publicado: (2006)

Combining Gene Signatures Improves Prediction of Breast Cancer Survival
por: Zhao, Xi, et al.
Publicado: (2011)

BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations
por: Holstege, Henne, et al.
Publicado: (2010)

Interleukin-8 is the single most up-regulated gene in whole genome profiling of H. pylori exposed gastric epithelial cells
por: Eftang, Lars L, et al.
Publicado: (2012)

Overrepresentation of transcription factor families in the genesets underlying breast cancer subtypes
por: Joshi, Himanshu, et al.
Publicado: (2012)

Cis-regulatory mutations associate with transcriptional and post-transcriptional deregulation of gene regulatory programs in cancers
por: Castro-Mondragon, Jaime A, et al.
Publicado: (2022)

Quantitative DNA methylation analyses reveal stage dependent DNA methylation and association to clinico-pathological factors in breast tumors
por: Klajic, Jovana, et al.
Publicado: (2013)

Up-regulation of CLDN1 in gastric cancer is correlated with reduced survival
por: Eftang, Lars L, et al.
Publicado: (2013)

The Sub-Cellular Localization of WRAP53 Has Prognostic Impact in Breast Cancer
por: Silwal-Pandit, Laxmi, et al.
Publicado: (2015)

Genes harbouring susceptibility SNPs are differentially expressed in the breast cancer subtypes
por: Nordgard, Silje H, et al.
Publicado: (2007)

DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response
por: Dejeux, Emelyne, et al.
Publicado: (2010)

Expression of wild-type and mutated TP53 in breast carcinomas
por: Baumbusch, LO, et al.
Publicado: (2005)

Somatic sequence alterations in twenty-one genes selected by expression profile analysis of breast carcinomas
por: Chanock, Stephen J, et al.
Publicado: (2007)

Optimization and evaluation of T7 based RNA linear amplification protocols for cDNA microarray analysis
por: Zhao, Hongjuan, et al.
Publicado: (2002)

Serum estradiol levels associated with specific gene expression patterns in normal breast tissue and in breast carcinomas
por: Haakensen, Vilde D, et al.
Publicado: (2011)

Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer
por: Muggerud, Aslaug Aa, et al.
Publicado: (2010)

Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling
por: Beck, Andrew H, et al.
Publicado: (2009)

Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms
por: Sørlie, Therese, et al.
Publicado: (2006)

Evaluation of MetriGenix custom 4D™ arrays applied for detection of breast cancer subtypes
por: Muggerud, Aslaug Aamodt, et al.
Publicado: (2006)

High‐throughput proteomics of breast cancer interstitial fluid: identification of tumor subtype‐specific serologically relevant biomarkers
por: Terkelsen, Thilde, et al.
Publicado: (2021)

Molecular subtyping for clinically defined breast cancer subgroups
por: Zhao, Xi, et al.
Publicado: (2015)

Expression of BMI-1 and Mel-18 in breast tissue - a diagnostic marker in patients with breast cancer
por: Riis, Margit LH, et al.
Publicado: (2010)

Mutations for the people
por: Kristensen, Vessela, et al.
Publicado: (2010)

HER-2 activation and TP53 inactivation as predictors of survival in breast cancer
por: Andersen, TI, et al.
Publicado: (2000)

In breast cancer subtypes steroid sulfatase (STS) is associated with less aggressive tumour characteristics
por: McNamara, Keely M, et al.
Publicado: (2018)

Genetics of validated Parkinson’s disease subtypes in the Oxford Discovery and Tracking Parkinson’s cohorts
por: Lawton, Michael, et al.
Publicado: (2022)

Local false discovery rate facilitates comparison of different microarray experiments
por: Hong, Wan-Jen, et al.
Publicado: (2009)

p16(INK4A) as a predictive factor in patients with locally advanced breast cancer treated with neoadjuvant doxorubicin monotherapy
por: Geisler, S, et al.
Publicado: (2000)

Prognostic Influence of BCL2 on Molecular Subtypes of Breast Cancer
por: Hwang, Ki-Tae, et al.
Publicado: (2017)

Expression levels of uridine 5'-diphospho-glucuronosyltransferase genes in breast tissue from healthy women are associated with mammographic density
por: Haakensen, Vilde D, et al.
Publicado: (2010)

Nuclear CSPP1 expression defined subtypes of basal-like breast cancer
por: Sternemalm, J, et al.
Publicado: (2014)

Workshop on The Epidemiology of the ATM Gene: Impact on Breast Cancer Risk and Treatment, Present Status and Future Focus, Lillehammer, Norway, 29 June 2002
por: Bernstein, Jonine L, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_dct25k08f7vbk5dm28d1l3a4ad